Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

May 14, 2020

KPH HEALTHCARE SERVICES, INC. et al v. JANSSEN BIOTECH, INC. et al

Track this case

Case Number:

2:20-cv-05901

Court:

New Jersey

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action

Judge:

Michael E. Farbiarz

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 12, 2021

    Janssen Wins Push To Arbitrate Zytiga Generic Delay Suit

    Janssen Biotech Inc. successfully persuaded a New Jersey federal judge to rule on Tuesday that arbiters must resolve a drugstore chain's antitrust suit accusing the pharma giant of unlawfully delaying a generic form of the prostate cancer drug Zytiga.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login